Skip to main content
Clinical Trials/DRKS00005250
DRKS00005250Completed未知

Evaluation of group psychotherapies to improve the self-regulation of overweight/obese people

Klinik für Kinder- und Jugendpsychiatrie der LWL-Universitätsklinik der Ruhr-Universität Bochum, Abt. Forschung0 sites101 target enrollmentStarted: November 29, 2013Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
101

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 45 Years (—)
Sex
All

Inclusion Criteria

  • Included are people with overweight (BMI 25 - 29.9 kg/m2) or obesity (BMI 30 - 39.9 kg/m2) grade I and II (278.00, E66.9) with pathological eating habits and/or people with Binge-Eating disorder (BED. 307.51, F50.8) by DSM-5 (APA, 2013), who want to reduce or stabilize their weight long-term. Uncontrolled overeating, grazing (atypical eating attacks), sweet eating, emotion-induced eating and/or at times strongly restricted eating behaviour within the meaning of rigide cognitive control are defined as pathological eating habits of overweight or obese people. Besides the subjects have made use of interventions of weight reduction, like autonomous dietary restraint and/or increase of physical activity, participation in conservative treatments for overweight or obesity and/or bariatric interventions as well as psychotherapeutic individual or group therapy. Thereby they failed long-term in stabilize their initial successful” weight reduction of at least 5-10% of their beginning weight. The age is limited to 18 to 45 years, to get an almost homogeneous group concerning the training of cognitive functions. The subjects should possess adequate knowledge of German and access to the Internet.

Exclusion Criteria

  • The subjects aren’t participating currently in other psychotherapeutic individual or group therapies. Furthermore exclusion criteria are Bulimia nervosa, Schizophrenia spectrum and other psychotic disorders, Substance-related and addictive disorders not in early or sustained remission, Neurocognitive disorders, Intellectual disabilities and severe untreated Borderline personality disorder by DSM-5 (APA, 2013) as well as acute suicidality. In case of severe physical diseases which could influence strongly the eating behavior (amongst others liver disease, diabetes mellitus, thyroid dysfunction), subjects were excluded on a case-by-case basis. Besides pregnant women can’t participate because of hormonal and physical changes and their potential influences on the measurements. Medication-induced weight gain, e.g. due to regular intake of weight loss drugs, lithium, weight-influenced antidepressants, lithium, methylphenidate, zyprexa, valproic acid, cortisone as well as sedatives, will carefully be considered in each individual case, depending on the effect size there can be an exclusion of subjects.

Investigators

Sponsor
Klinik für Kinder- und Jugendpsychiatrie der LWL-Universitätsklinik der Ruhr-Universität Bochum, Abt. Forschung

Similar Trials